Kejriwals Stone Clinic And Kidney Care Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 19-12-2024
- Paid Up Capital ₹ 1.30 M
as on 19-12-2024
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 55.31%
(FY 2022)
- Profit 307.75%
(FY 2022)
- Ebitda 148.13%
(FY 2022)
- Net Worth 29.57%
(FY 2022)
- Total Assets 86.02%
(FY 2022)
About Kejriwals Stone Clinic And Kidney Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.30 M, as per Ministry of Corporate Affairs (MCA) records.
Sangita Kejriwal, Nischhal Kejriwal, Nehal Kejriwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110WB2005PTC104477
- Company No.
104477
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Darjiling, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Kejriwals Stone Clinic And Kidney Care?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangita Kejriwal  | Director | 01-Aug-2005 | Current |
| Nischhal Kejriwal | Director | 24-Jan-2020 | Current |
| Nehal Kejriwal | Director | 24-Jan-2020 | Current |
| Niranjan Kejriwal | Director | 01-Aug-2005 | Current |
Financial Performance of Kejriwals Stone Clinic And Kidney Care.
Kejriwals Stone Clinic And Kidney Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 55.31% increase. The company also saw a substantial improvement in profitability, with a 307.75% increase in profit. The company's net worth Soared by an impressive increase of 29.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kejriwals Stone Clinic And Kidney Care?
In 2022, Kejriwals Stone Clinic And Kidney Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nischal Share & Stocks Advisory LlpActive 9 years 10 monthsSangita Kejriwal and Niranjan Kejriwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kejriwals Stone Clinic And Kidney Care?
Kejriwals Stone Clinic And Kidney Care has a workforce of 5 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kejriwals Stone Clinic And Kidney Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kejriwals Stone Clinic And Kidney Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
